Skip to search formSkip to main contentSkip to account menu

inolimomab

National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

BT 563

Broader (1)

Monoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Inolimomab in steroid-resistant aGvHD 1 A phase III randomized trial comparing Inolimomab vs . Usual care in steroid-resistant acute GVHD
Service thérapie cellulaire et hématologie clinique, CHU, Clermont-Ferrand, France; 7 Unité de Transplantation et de Thérapie… 
2008
2008
Pharmacologic intervention for cancer-related dyspnea.
1. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2002
Review
2002
Inolimomab (OPi).
OPi (formerly Orphan Pharma International) is developing inolimomab, an anti-interleukin-2 receptor (CD25) monoclonal antibody… 
1999
1999
Inolimomab. Anti-CD25 monoclonal antibody B-B10, anti-interleukin-2 receptor monoclonal antibody B-B10, B-B10, BT 563, Leukotac.
1997
1997
Potential of Anti-Interleukin-2 Receptor Monoclonal Antibodies in Solid Organ Transplantation
SummaryMonoclonal and polyclonal antibody preparations have been used for induction therapy after organ transplantation. Apart… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)